SEC Form 4 · accession 0001144204-15-021067
PALISADE BIO, INC. · PALI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Garr
Officer — CEO · Director
Period of report
Feb 20, 2015
Accepted (ET)
Apr 2, 2015 · 7:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001357459
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Purchase OptionF1 | $3.80 | Feb 20, 2015 | A | 171,008 | A | Feb 20, 2015 | Feb 20, 2025 | Common Stock | 171,008 | 171,008 | D |
Explanation of responses
- F1Represents long term incentive bonus. The options vest quarterly over three years commencing on 2/20/2015.